Results 41 to 50 of about 2,297 (166)

Cutaneous and non‐cutaneous diseases due to Mycoplasma pneumoniae in children

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 464-469, April 2026.
Summary Mycoplasma pneumoniae (MP) is a common pathogen responsible for diverse infections in children and adolescents, primarily affecting the respiratory tract. Besides causing atypical pneumonia, MP can also lead to extrapulmonary manifestations, including mucocutaneous, hematological, neurological, cardiac, and gastrointestinal symptoms.
Hanna Lindemann, Maximilian David Mauritz, Victoria Rehmann, Michael Paulussen, Jorge Frank, Malik Aydin   +5 more
wiley   +1 more source

A clinical study on pityriasis rosea

Indian Journal of Dermatology, 2005
Pityriasis rosea is an acute inflammatory dermatosis of unknown etiology with a self-limited course. Fifty patients of pityriasis rosea attending out patient department of our hospital were selected for the study and the data was analysed. In the present
Egwin Anand, Martis Jacintha, Bhat Ramesh, Kamath Ganesh, Nanda Kishore   +4 more
doaj  

Kutane und nichtkutane Erkrankungen durch Mycoplasma pneumoniae bei Kindern

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 464-470, April 2026.
Zusammenfassung Mycoplasma pneumoniae (MP) ist ein häufiger Erreger verschiedener Infektionen bei Kindern und Jugendlichen, die vor allem die Atemwege betreffen. Neben atypischen Pneumonien kann MP auch zu extrapulmonalen Manifestationen führen, darunter mukokutane, hämatologische, neurologische, kardiale und gastrointestinale Symptome.
Hanna Lindemann, Maximilian David Mauritz, Victoria Rehmann, Michael Paulussen, Jorge Frank, Malik Aydin   +5 more
wiley   +1 more source

Pityriasis rosea revealing a viral Hepatitis B

Revue Malienne d’Infectiologie et de Microbiologie, 2017
Pityriasis rosea, described by Gibert in 1860, is a frequent, benign, transient dermatosis, with unknown etiology that affects especially young adults. It is believed to be a consequence of a viral infection, but this argument is not convincing.
Y Karabinta, O Faye, I Konaté, O Sylla, A Dicko, L Cissé, M Gassama, B Traoré, Y Fofana, S Touré, S Dao   +10 more
doaj   +1 more source

A multiplex real-time PCR quantitation of human herpesvirus-6, 7, 8 viruses: application in blood transfusions

Virology Journal, 2021
Background In recent years, fluorescent quantitative polymerase chain reaction assays for detecting viral DNA are in widespread use throughout the world. However, considering the wide distribution of new herpesvirus among the population, we constructed a
Yi Zheng, Youyun Zhao, Yefu Wang, Jun Rao   +3 more
doaj   +1 more source

Population‐Based Multi‐Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease

Advanced Science, Volume 13, Issue 8, 9 February 2026.
Psoriatic disease (PsD) is a chronic skin disease, with challenges in early risk stratification and drug development. Through gene‐level causal inference framework and expression level validation, combined with longitudinal cohort study, CDSN and PRSS8 have been identified as candidate biomarkers and therapeutic targets for PsD.
Tianxing Wu, Jialiang Luo, Haoyuan Qiu, Weijie Shao, Yueyang Lu, Meixuan Luo, Zhaofeng Lin, Yan Zhang, Libo Zhang, Hong Wang, Jia Zhou, Guangfeng Ruan, Peihua Cao, Daming Zuo   +13 more
wiley   +1 more source

Physeal Allograft Transfer for Physeal Bars: A Safety and Feasibility Study in a Domestic Swine Model

Journal of Orthopaedic Research, Volume 44, Issue 1, January 2026.
ABSTRACT Premature physeal closure occurs following trauma, cancer, or infection. Current treatments have poor success rates. With recent pediatric donor tissue availability, physeal allograft transfer (PAT) can now be considered. The purpose of this study was to study the safety and feasibility of PAT in a large animal model.
J. V. Korpershoek, C. Chen, C. V. Nagelli, K. L. Lydon, M. L. Floren, D. B. F. Saris, A. N. Larson, T. A. Milbrandt   +7 more
wiley   +1 more source

Interventions for pityriasis rosea

Cochrane Database of Systematic Reviews, 2019
Pityriasis rosea is a scaly, itchy rash that mainly affects young adults and lasts for 2 to 12 weeks. The effects of many available treatments are uncertain. This is an update of a Cochrane Review first published in 2007.To assess the effects of interventions for the management of pityriasis rosea in any individual diagnosed by a medical practitioner ...
Contreras‐Ruiz, Jose, Peternel, Sandra, Jiménez Gutiérrez, Carlos, Čulav‐Košćak, Ivana, Reveiz, Ludovic, de Lourdes Silbermann‐ Reynoso, Maria   +5 more
openaire   +4 more sources

Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page 29-45, January 2026.
There is a concerning trend of widespread and severe superficial fungal infections caused by a new pathogen—Trichophyton indotineae—resistant to standard antifungal therapies. T. indotineae is now spreading globally and evolving. There is increasing urgency for healthcare providers and policy makers to initiate surveillance systems and antifungal ...
Aditya K. Gupta, Susmita, Hien C. Nguyen, Amanda Liddy, Mesbah Talukder, Tong Wang, Lee Magal, Anuradha Chowdhary, Avner Shemer, Ditte Marie L. Saunte, Roderick Hay, Vincent Piguet   +11 more
wiley   +1 more source

Off‐Label Use of Selective JAK1 Inhibitors in Immune‐Mediated Inflammatory Skin Diseases: A Retrospective Case Series

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
This article aimed to evaluate the efficacy and safety of JAK1 inhibitors (abrocitinib and upadacitinib) in off‐label treatment of refractory inflammatory skin diseases. We retrospectively analyzed 19 patients with various immune‐mediated dermatoses, including cutaneous lichen planus, parapsoriasis, vitiligo, autoimmune bullous diseases ...
Si Zhang, Xinnuo Chen, Maoying Li, Xi Wang, Cuihong Lian, Aditya Gupta   +5 more
wiley   +1 more source